GE HealthCare Techs Q3 2024 Adj EPS $1.14 Beats $1.05 Estimate, Sales $4.86B Miss $4.87B Estimate
Portfolio Pulse from Benzinga Newsdesk
GE HealthCare Techs reported Q3 2024 earnings per share of $1.14, surpassing the analyst estimate of $1.05, marking a 15.15% increase from last year. However, sales of $4.86 billion slightly missed the $4.87 billion estimate, though they were up 0.85% from the previous year.
October 30, 2024 | 10:21 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
GE HealthCare Techs reported better-than-expected Q3 2024 EPS of $1.14, beating estimates by 8.57%, but sales slightly missed expectations at $4.86B. The earnings beat is a positive indicator, but the sales miss may temper investor enthusiasm.
The earnings per share (EPS) beat the consensus estimate by 8.57%, which is a strong positive signal for investors and could lead to a short-term stock price increase. However, the slight miss in sales, although minor, may limit the extent of the positive impact. Overall, the earnings beat is likely to outweigh the sales miss, leading to a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100